Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$737M |
| 2 |
Invesco S&P 500 Revenue ETF
RWL
|
+$669M |
| 3 |
Bank of America
BAC
|
+$513M |
| 4 |
Amazon
AMZN
|
+$510M |
| 5 |
Canadian Pacific Kansas City
CP
|
+$482M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco S&P 500 Pure Value ETF
RPV
|
+$491M |
| 2 |
Trade Desk
TTD
|
+$466M |
| 3 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$373M |
| 4 |
Eli Lilly
LLY
|
+$367M |
| 5 |
Williams-Sonoma
WSM
|
+$295M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.41% |
| 2 | Financials | 13.31% |
| 3 | Industrials | 11.28% |
| 4 | Healthcare | 10.55% |
| 5 | Consumer Discretionary | 10.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3626
Perspective Therapeutics
CATX
$322M
| $48.4K | ﹤0.01% |
22,742
-2,432
| -10% | -$7.3K |
|
3627
Sera Prognostics
SERA
$80.3M
| $48.3K | ﹤0.01% |
13,124
-584
| -4% | -$2.98K |
|
3628
Dakota Gold
DC
$604M
| $48.1K | ﹤0.01% |
18,150
+230
| +1% | +$631 |
|
3629
Gossamer Bio
GOSS
$92.9M
| $48.1K | ﹤0.01% |
+43,697
| New | +$50.5K |
|
3630
ALX Oncology
ALXO
$261M
| $46K | ﹤0.01% |
+73,836
| New | +$88.6K |
|
3631
Stereotaxis
STXS
$133M
| $45.8K | ﹤0.01% |
26,025
-971
| -4% | -$2.07K |
|
3632
Eve Holding
EVEX
$791M
| $45.8K | ﹤0.01% |
13,789
+2,344
| +20% | +$10.1K |
|
|
MAPS
3633
DELISTED
WM TECHNOLOGY INC A
MAPS
| $44.9K | ﹤0.01% |
39,769
-1,688
| -4% | -$2.25K |
|
3634
Design Therapeutics
DSGN
$742M
| $43.7K | ﹤0.01% |
11,331
-252
| -2% | -$1.2K |
|
3635
loanDepot
LDI
$542M
| $43.5K | ﹤0.01% |
+36,576
| New | +$59.3K |
|
3636
Wheels Up
UP
$194M
| $42.9K | ﹤0.01% |
2,124
-103
| -5% | -$2.84K |
|
|
IGMS
3637
DELISTED
IGM Biosciences
IGMS
| $41.5K | ﹤0.01% |
+36,127
| New | +$67.2K |
|
3638
Lantronix
LTRX
$221M
| $41K | ﹤0.01% |
16,460
+1,245
| +8% | +$4.01K |
|
3639
Lightwave Logic
LWLG
$830M
| $39.6K | ﹤0.01% |
38,665
-2,777
| -7% | -$4.33K |
|
|
QIPT
3640
DELISTED
Quipt Home Medical
QIPT
| $39.6K | ﹤0.01% |
16,981
-678
| -4% | -$1.86K |
|
|
MRSN
3641
DELISTED
Mersana Therapeutics
MRSN
| $39.5K | ﹤0.01% |
4,595
+2,400
| +109% | +$37K |
|
3642
Atossa Therapeutics
ATOS
$23M
| $39.5K | ﹤0.01% |
3,911
-112
| -3% | -$1.36K |
|
3643
Immunic
IMUX
$175M
| $38.6K | ﹤0.01% |
3,541
-140
| -4% | -$1.51K |
|
3644
1stdibs.com
DIBS
$150M
| $35.9K | ﹤0.01% |
11,805
-359
| -3% | -$1.29K |
|
|
ZYXI
3645
DELISTED
Zynex
ZYXI
| $34.9K | ﹤0.01% |
15,868
-4,888
| -24% | -$31.9K |
|
3646
Larimar Therapeutics
LRMR
$384M
| $34.6K | ﹤0.01% |
16,112
-148
| -0.9% | -$468 |
|
3647
Denison Mines
DNN
$2.37B
| $34.5K | ﹤0.01% |
26,543
+31
| +0.1% | +$52 |
|
|
CVAC
3648
DELISTED
CureVac
CVAC
| $34.3K | ﹤0.01% |
12,376
+836
| +7% | +$2.91K |
|
3649
Verrica Pharmaceuticals
VRCA
$92.9M
| $32.9K | ﹤0.01% |
7,439
+2,926
| +65% | +$18.9K |
|
3650
Nerdy
NRDY
$107M
| $32.3K | ﹤0.01% |
22,748
-1,131
| -5% | -$1.9K |
|
Similar funds
Invesco's Q1 2025 Portfolio in Review
As of Q1 2025, Invesco held 3,856 positions worth $528B, down 2.4% from $541B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Invesco's Q1 2025 filing shows 117 new, 1,793 increased, 1,749 reduced and 89 closed positions. Its largest new stake was Invesco Managed Futures Strategy ETF: 4,184,000 shares worth $206M. The largest sale was Invesco S&P 500 Pure Value ETF, an estimated $491M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Financials and Industrials.
- Invesco's largest Q1 2025 buy was Invesco Managed Futures Strategy ETF: 4,184,000 shares worth $206M.
- Invesco added most to Tesla in Q1 2025, an estimated $737M increase.
- Invesco's biggest Q1 2025 reduction was Invesco S&P 500 Pure Value ETF, cutting an estimated $491M.
- Invesco fully exited ENLINK MIDSTREAM, LLC in Q1 2025, selling an estimated $281M.
- Invesco's ten largest holdings make up 17% of its $528B portfolio in Q1 2025.
- Invesco opened 117 new positions and closed 89 in Q1 2025.
- Invesco's portfolio value fell 2.4% quarter-over-quarter to $528B.
Based on Invesco's 13F filing for Q1 2025, filed 12 May 2025.